Hypertension, Malignant
"Hypertension, Malignant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Descriptor ID |
D006974
|
MeSH Number(s) |
C14.907.489.330
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Malignant".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Malignant".
This graph shows the total number of publications written about "Hypertension, Malignant" by people in UAMS Profiles by year, and whether "Hypertension, Malignant" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 1 | 1 | 2 | 2016 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypertension, Malignant" by people in Profiles over the past ten years.
-
Magvanjav O, Cooper-DeHoff RM, McDonough CW, Gong Y, Segal MS, Hogan WR, Johnson JA. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease. J Clin Hypertens (Greenwich). 2019 01; 21(1):91-101.
-
Sedl?kov? L, Kikerlov? S, Huskov? Z, Cervenkov? L, Ch?bov? VC, Zicha J, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Kr?tk? V, Cervenka L, Kopkan L. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats. Biosci Rep. 2018 10 31; 38(5).
-
Baradhi KM, Tran T, Mittadodla PS. 'Malignant' hypertension from hyperaldosteronism: a case report. Pan Afr Med J. 2018; 30:10.
-
J?chov? ?, Kopkan L, Huskov? Z, Dole?elov? ?, Neck?r J, Kujal P, Vernerov? Z, Kramer HJ, Sadowski J, Kompanowska-Jezierska E, Reddy RN, Falck JR, Imig JD, Cervenka L. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats. J Hypertens. 2016 10; 34(10):2008-25.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|